ATE430126T1 - Neue dibenzoäb,füoxepin-10-carbonsäureamide und deren pharmazeutische anwendungen - Google Patents

Neue dibenzoäb,füoxepin-10-carbonsäureamide und deren pharmazeutische anwendungen

Info

Publication number
ATE430126T1
ATE430126T1 AT04763454T AT04763454T ATE430126T1 AT E430126 T1 ATE430126 T1 AT E430126T1 AT 04763454 T AT04763454 T AT 04763454T AT 04763454 T AT04763454 T AT 04763454T AT E430126 T1 ATE430126 T1 AT E430126T1
Authority
AT
Austria
Prior art keywords
füoxepin
dibenzoäb
new
carbonic acid
acid amides
Prior art date
Application number
AT04763454T
Other languages
English (en)
Inventor
Yves Auberson
Claudia Betschart
Stefanie Flohr
Ralf Glatthar
Oliver Simic
Marina Tintelnot-Blomley
Thomas Troxler
Eric Vangrevelinghe
Siem Veenstra
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE430126T1 publication Critical patent/ATE430126T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/82—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14—[b,f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
    • C07C2603/32—Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04763454T 2003-07-25 2004-07-23 Neue dibenzoäb,füoxepin-10-carbonsäureamide und deren pharmazeutische anwendungen ATE430126T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0317491.9A GB0317491D0 (en) 2003-07-25 2003-07-25 Organic compounds
PCT/EP2004/008283 WO2005014517A2 (en) 2003-07-25 2004-07-23 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof

Publications (1)

Publication Number Publication Date
ATE430126T1 true ATE430126T1 (de) 2009-05-15

Family

ID=27772721

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04763454T ATE430126T1 (de) 2003-07-25 2004-07-23 Neue dibenzoäb,füoxepin-10-carbonsäureamide und deren pharmazeutische anwendungen

Country Status (16)

Country Link
US (1) US7612054B2 (de)
EP (1) EP1651592B1 (de)
JP (1) JP2006528610A (de)
CN (1) CN100513387C (de)
AT (1) ATE430126T1 (de)
AU (1) AU2004263286B2 (de)
BR (1) BRPI0412928A (de)
CA (1) CA2533174A1 (de)
DE (1) DE602004020896D1 (de)
ES (1) ES2324615T3 (de)
GB (1) GB0317491D0 (de)
HK (1) HK1090354A1 (de)
MX (1) MXPA06000914A (de)
PL (1) PL1651592T3 (de)
PT (1) PT1651592E (de)
WO (1) WO2005014517A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351738B2 (en) * 2002-11-27 2008-04-01 Elan Pharmaceuticals, Inc. Substituted ureas and carbamates
US20050239836A1 (en) 2004-03-09 2005-10-27 Varghese John Substituted hydroxyethylamine aspartyl protease inhibitors
WO2005087714A2 (en) * 2004-03-09 2005-09-22 Elan Pharmaceuticals, Inc. Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors
US7385085B2 (en) 2004-07-09 2008-06-10 Elan Pharmaceuticals, Inc. Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
JP2008505929A (ja) * 2004-07-09 2008-02-28 エラン ファーマシューティカルズ，インコーポレイテッド オキシム誘導体ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬
WO2007047305A1 (en) 2005-10-12 2007-04-26 Elan Pharmaceuticals, Inc. Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
EP1971598A1 (de) * 2005-11-21 2008-09-24 Amgen Inc. Beta-sekretase-modulatoren und anwendungsverfahren
RU2483061C2 (ru) * 2007-07-05 2013-05-27 Шеринг Корпорейшн Тетрагидропиранохроменовые ингибиторы гамма-секретазы

Also Published As

Publication number Publication date
DE602004020896D1 (de) 2009-06-10
EP1651592B1 (de) 2009-04-29
BRPI0412928A (pt) 2006-09-26
ES2324615T3 (es) 2009-08-11
WO2005014517A3 (en) 2005-04-28
PL1651592T3 (pl) 2009-10-30
JP2006528610A (ja) 2006-12-21
AU2004263286B2 (en) 2009-01-15
AU2004263286A1 (en) 2005-02-17
CN100513387C (zh) 2009-07-15
CA2533174A1 (en) 2005-02-17
WO2005014517A2 (en) 2005-02-17
US20070111991A1 (en) 2007-05-17
CN1823036A (zh) 2006-08-23
MXPA06000914A (es) 2006-03-30
GB0317491D0 (en) 2003-08-27
US7612054B2 (en) 2009-11-03
EP1651592A2 (de) 2006-05-03
PT1651592E (pt) 2009-07-23
HK1090354A1 (en) 2006-12-22

Similar Documents

Publication Publication Date Title
MY140693A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
BG108650A (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
SE0301010D0 (sv) Novel compounds
SE0104340D0 (sv) New compounds
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
GEP20012555B (en) Pyrazine Compounds, Method for Its Production, Their Use As a Medicinal Means, Pharmaceutical Composition and Method for Treatment
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
MY147588A (en) (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
EP1725536B8 (de) Imidazolinderivate mit cb1-antagonistischer wirkung
HK1090354A1 (en) Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
MX2009014001A (es) Derivados de isoxazol-imidazol.
MX2009005507A (es) Derivados de espiro-piperidina.
ATE367387T1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
MY146802A (en) Novel drugs for treating respiratory diseases
BRPI0607918A2 (pt) tetraidro-piridoazepin-8-onas e compostos relacionados para o tratemento da esquizofrenia.
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
TW200740440A (en) Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
WO2008078453A1 (ja) 血小板産生促進因子及びその利用
BR0000901A (pt) Derivados 4-fenil-4-heteroarilpiperidina
AU2001266019A1 (en) 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
IL163025A (en) Prucalopride - n - oxides, their preparation and pharmaceutical compositions comprising them
ATE440826T1 (de) Benzoxazolonderivate, verfahren zu deren herstellung und deren anwendungen
ATE513841T1 (de) Neue thioxyloseverbindungen, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und deren verwendung in therapeutika

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1651592

Country of ref document: EP

REN Ceased due to non-payment of the annual fee